Sebastian Soluch

Sebastian Soluch is a prominent Health Economics and Market Access executive with a broad international experience in the pharmaceutical industry, particularly in areas like oncology, vaccines, orphan drugs, radiopharmaceuticals, and diagnostics. His expertise lies in shaping Global Value Dossiers (GVDs), value propositions, and market access strategies, running phase III studies, conducting quality-of-life research, and analyzing national healthcare systems. With a focus on health economics components, he excels in post-marketing studies, pricing strategies, NPV optimization, and navigating the complexities of healthcare systems globally. Sebastian has a strong background in developing pharmacoeconomics materials and market access strategies and has led successful submissions to HTA bodies across EMEA, USA, Canada, and Japan, ensuring the economic viability of medicines in healthcare systems.

Sebastian Soluch holds a Doctor of Philosophy (Ph.D.) from the Medical University of Lublin, an MBA from Maastricht School of Management, and a Master's Degree from the Medical University of Lublin. He has also studied at the University of York, enhancing his academic prowess in the fields relevant to his professional expertise.

With a solid career trajectory, Sebastian has held key leadership positions in renowned organizations. He is currently the Head of Market Access and Pricing for Region Europe at Stemline Therapeutics, Inc. Prior to this role, he served as the Global Head of Market Access at Advanced Accelerator Applications and as the European Market Access Director at CSL Behring. Sebastian has also contributed significantly in previous roles at Allergan, Sanofi Pasteur, Novartis, and Solvay, where he held various strategic and managerial positions focusing on health economics, pricing, reimbursement, and market access. Additionally, he has experience as an Assistant Professor at the Medical University of Lublin, further showcasing his expertise in academia and practical industry applications.